IMMUTEP LIMITED - AMER
2.0500
07-10月-24 15:59:57
15 分の遅延
株式
0.0000
0.00%
本日の幅
2.0200 - 2.0900
ISIN
N/A
ソース
NASDAQ
-
Immutep Quarterly Activities Report Q4 FY23
31 7 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
31 7 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
28 7 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Completes A$80 Million Capital Raise
27 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
27 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Immutep Granted United States Patent for IMP761, a First-in-Class Agonist Antibody Targeting LAG-3
20 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Immutep to Participate at the Jefferies Healthcare Conference
07 6 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
05 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
02 6 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study
29 5 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting
26 5 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Doses First Patient in AIPAC-003 Phase II/III Trial for Metastatic Breast Cancer
25 5 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Announces Promising New Clinical Data from Triple Combination Therapy in INSIGHT-003 Trial
24 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
17 5 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
16 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Immutep to Participate in the JMP Securities Life Sciences Conference
09 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
02 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
01 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
27 4 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
Immutep Announces Presentation of New TACTI-002 Data at the 2023 ASCO Annual Meeting
26 4 2023 10:00:00 提供 Nasdaq GlobeNewswire